全文获取类型
收费全文 | 109684篇 |
免费 | 9499篇 |
国内免费 | 2497篇 |
出版年
2023年 | 560篇 |
2022年 | 1160篇 |
2021年 | 2244篇 |
2020年 | 1519篇 |
2019年 | 1891篇 |
2018年 | 2062篇 |
2017年 | 1652篇 |
2016年 | 2626篇 |
2015年 | 4377篇 |
2014年 | 4934篇 |
2013年 | 6188篇 |
2012年 | 7534篇 |
2011年 | 7507篇 |
2010年 | 4776篇 |
2009年 | 4288篇 |
2008年 | 5975篇 |
2007年 | 5892篇 |
2006年 | 5561篇 |
2005年 | 5276篇 |
2004年 | 5280篇 |
2003年 | 4721篇 |
2002年 | 4617篇 |
2001年 | 1585篇 |
2000年 | 1263篇 |
1999年 | 1468篇 |
1998年 | 1499篇 |
1997年 | 1165篇 |
1996年 | 1080篇 |
1995年 | 1001篇 |
1994年 | 1001篇 |
1993年 | 861篇 |
1992年 | 942篇 |
1991年 | 893篇 |
1990年 | 824篇 |
1989年 | 842篇 |
1988年 | 719篇 |
1987年 | 665篇 |
1986年 | 604篇 |
1985年 | 743篇 |
1984年 | 884篇 |
1983年 | 739篇 |
1982年 | 848篇 |
1981年 | 851篇 |
1980年 | 779篇 |
1979年 | 574篇 |
1978年 | 625篇 |
1977年 | 584篇 |
1976年 | 592篇 |
1974年 | 573篇 |
1973年 | 505篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
51.
52.
A recent literature review of commentaries and ‘state of the art’ articles from researchers in psychiatric genetics (PMG)
offers a consensus about progress in the science of genetics, disappointments in the discovery of new and effective treatments,
and a general optimism about the future of the field. I argue that optimism for the field of psychiatric molecular genetics
(PMG) is overwrought, and consider progress in the field in reference to a sample estimate of US National Institute of Mental
Health funding for this paradigm for the years 2008 and 2009. I conclude that the amounts of financial investment in PMG is
questionable from an ethical perspective, given other research and clinical needs in the USA. 相似文献
53.
John M. Miller 《BMJ (Clinical research ed.)》1889,2(1506):1063-1064
54.
55.
Shashank Hambarde Chi-Lin Tsai Raj K. Pandita Albino Bacolla Anirban Maitra Vijay Charaka Clayton R. Hunt Rakesh Kumar Oliver Limbo Remy Le Meur Walter J. Chazin Susan E. Tsutakawa Paul Russell Katharina Schlacher Tej K. Pandita John A. Tainer 《Molecular cell》2021,81(14):2989-3006.e9
- Download : Download high-res image (222KB)
- Download : Download full-size image
56.
Tsai-Ling Liao Ching-Heng Lin Yi-Ming Chen Chia-Li Chang Hsin-Hua Chen Der-Yuan Chen 《PloS one》2016,11(4)
Increasing evidence indicates an increased risk of tuberculosis (TB) for rheumatoid arthritis (RA) patients receiving biologic therapy, and the effectiveness of isoniazid prophylaxis (INHP) in TB prevention. We aimed to examine 1) the incidence rate (IR) and risk factors for TB among RA patients receiving different therapies; 2) INHP effectiveness for TB prevention; 3) mortality rates after TB diagnosis in patients receiving different therapies. This retrospective study was conducted using a nationwide database: 168,720 non-RA subjects and a total of 42,180 RA patients including 36,162 csDMARDs-exposed, 3,577 etanercept-exposed, 1,678 adalimumab-exposed and 763 rituximab-exposed patients. TB risk was 2.7-fold higher in RA cohort compared with non-RA group, with an adjusted hazard ratio (aHR) of 2.58. Advanced age, male, the use of corticosteroids≧5mg/day, and the presence of diabetes mellitus (DM), chronic obstructive pulmonary disease and chronic kidney disease were risk factors for developing TB. Using csDMARDs-exposed group as reference, aHR of TB was the highest with adalimumab treatment (1.52), followed by etanercept (1.16), and the lowest with rituximab (0.08). INHP could effectively reduce TB risk in biologics-exposed patients. Mortality rates after TB diagnosis were higher in RA patients, particularly the elderly and those with DM, with lower rates in adalimumab-exposed patients compared with csDMARDs-exposed patients. In conclusion, TB risk was increased in patients receiving TNF-α inhibitors, but the risk associated with rituximab therapy was relatively low. With the effectiveness of INHP shown in the prevention of biologics-associated TB, stricter implementation of INHP should be beneficial. The mortality from biologics–associated TB may be efficiently reduced through increased awareness. 相似文献
57.
Predator detection and avoidance by starlings under differing scenarios of predation risk 总被引:3,自引:0,他引:3
Devereux Claire L.; Whittingham Mark J.; Fernandez-Juricic Esteban; Vickery Juliet A.; Krebs John R. 《Behavioral ecology》2006,17(2):303-309
Practically all animals must find food while avoiding predators.An individual's perception of predation risk may depend on manyfactors, such as distance to refuge and group size, but it isunclear whether individuals respond to different factors ina similar manner. We tested whether flocks of foraging starlingsresponded in the same way to an increased perception of predationrisk by assessing three factors: (1) neighbor distances, (2)habitat obstruction, and (3) recent exposure to a predator.We found that in all three scenarios of increased risk, starlingsreduced their interscan intervals (food-searching bouts), whichincreased the frequency of their vigilance periods. We thenexamined how one of these factors, habitat obstruction, affectedescape speed by simulating an attack with a model predator.Starlings were slower to respond in visually obstructed habitats(long grass swards) and slower when they had their head downin obstructed habitats than when they had their head down inopen habitats. In addition, reaction times were quicker whenstarlings could employ their peripheral fields of vision. Ourresults demonstrate that different sources of increased riskcan generate similar behavioral responses within a species.The degree of visibility in the physical and social environmentaffects both the actual and perceived risk of predation. 相似文献
58.
N-糖蛋白去糖基化酶(PNGase)是一种广泛存在于真菌、植物、哺乳动物中的去糖基化酶,可以水解N-糖蛋白或 N-糖肽上天冬酰胺与寡糖链连接的化学键,并释放出完整的N-寡糖。PNGase在生物体内参与蛋白质降解、器官发育、个体生长等过程。人PNGase基因功能缺陷会导致先天性去糖基化障碍,小鼠PNGase缺陷会导致胚胎致死性,线虫PNGase缺陷使其寿命下降。本文对PNGase在不同物种的分布、蛋白质结构、酶学功能及生物学功能进行阐述,为PNGase的生理病理功能及致病机制的基础研究提供思路,为PNGase作为糖生物学工具酶或药物开发的创新应用研究奠定基础。 相似文献
59.
Masaru Kubota Ying-Wei Lin Keigo Hamahata Machiko Sawada Seiji Koishi Haruyo Hirota Yoshihiro Wakazono 《Mutation Research - Genetic Toxicology and Environmental Mutagenesis》2000,470(2):21
The occurrence of a second neoplasm is one of the major obstacles in cancer chemotherapy. The elucidation of the genotoxic effects induced by anti-cancer drugs is considered to be helpful in identifying the degree of cancer risk. Numerous investigations on cancer patients after chemotherapy have demonstrated: (i) an increase in the in vivo somatic cell mutant frequency (Mf) at three genetic loci, including hypoxanthine–guanine phosphoribosyl-transferase (hprt), glycophorin A (GPA), and the T-cell receptor (TCR), and (ii) alterations in the mutational spectra of hprt mutants. However, the time required for and the degree of such changes are quite variable among patients even if they have received the same chemotherapy, suggesting the existence of underlying genetic factor(s). Accordingly, some cancer patients prior to chemotherapy as well as patients with cancer-prone syndrome have been found to show an elevated Mf. Based on the information obtained from somatic cell mutation assays, an individualized chemotherapy should be considered in order to minimize the risk of a second neoplasm. 相似文献
60.